Shares to buy now: two FTSE 100 fallers I’d consider

While the index has risen, our writer reveals two FTSE 100 fallers over the past year he would consider as shares to buy now for his portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 index of leading UK shares has increased 18% over the past year, rewarding many investors handsomely. But some FTSE 100 constituents have slumped in the face of a rising market. Here are two FTSE 100 fallers I think offer value and would consider adding to my portfolio.

FTSE 100 fallers: Smith & Nephew

Medical devices manufacturer Smith & Nephew (LSE: SN) has seriously lagged its FTSE 100 peers over the last year, shedding 18% of its value in the period.

That’s not without reason. The company suffered significant revenue falls as delays in elective surgeries hurt demand for some of its products. Even now, the company’s orthopaedics business sector continues to perform sluggishly, although revenues in the first half did rise slightly above those of the pre-pandemic 2019 first half.

However, while recovery may be coming slowly, I think investors have marked Smith & Nephew down more than is merited. The company’s position among FTSE 100 fallers suggests dim prospects. Yet all three of the company’s business areas reported stronger revenue in the first half than in the equivalent 2019 period – in the case of advanced wound management, revenue grew in double digits.

Long-term appeal

Revenue growth isn’t the only reason Smith & Nephew features on my list of shares to buy now for my portfolio, though.

I like the medical devices space in general. Healthcare spending tends to be resilient, and healthcare providers are willing to pay for well-known brands. That helps a company like Smith & Nephew, with a reputation for quality. The company has maintained its guidance for this year and continues to target trading profit margins of 18%-19%.

However, the Smith & Nephew share price does face continued risks. Any further lockdowns in some markets delaying elective surgery could again hurt both revenues and profits.

FTSE 100 fallers: Reckitt

Another blue chip company among the FTSE fallers over the past year is Reckitt (LSE: RKT). The consumer goods group owns brands such as Dettol and Finish. But its own finish to the past 12 months has been weak, with the Reckitt share price tumbling even more than Smith & Nephew. Reckitt shares have fallen 25% in the period.

Like Smith & Nephew, that’s not without cause – two main causes, in fact.

First is cost inflation. The company has warned that galloping input cost rises threaten profit margins if it can’t pass them onto consumers. Secondly, the company’s problematic infant formula division continues to trouble the share price. It sold its Chinese infant formula division last month, retaining a small stake in the new business. But the challenges of the business unit and the debt its acquisition added to Reckitt’s balance sheet continue to weigh on the Reckitt share price.

Reckitt: shares to buy now?

Against that background, I would consider Reckitt among shares to buy now for my portfolio.

The company’s collection of premium brands means it has pricing power. That should help it fight the challenge of inflation. The sale of the Chinese formula business shows the company is tackling its problems directly. Meanwhile, the shares yield 3.2% and offer exposure to a global business which owns an attractive set of brands.

There are risks: debt continues to limit dividend increases, and any economic downturn could lead to a fall in revenue. But Reckitt and Smith & Nephew are two FTSE 100 fallers I’d consider adding to my portfolio today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Christopher Ruane has no position in any shares mentioned. The Motley Fool UK has recommended Reckitt plc and Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »